Oblique Therapeutics
G├╢teborg
About Oblique Therapeutics
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Last round: Series Unknown (Dec 2015)
- Website: obliquet.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/oblique-therapeutics-2813710 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.